v3.26.1
Company Financial Statements (Parent Company Only)
12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Company Financial Statements
29. Company Financial Statements (Parent Company Only)
The Company performed a test on the restricted net assets of its consolidated subsidiaries and VIEs in accordance with Securities and Exchange Commission Regulation
S-X
Rule
4-08
(e) (3), “General Notes to Financial Statements” and concluded that it was applicable for the Company to disclose the financial information for the Company only (parent company only).
The subsidiaries did not pay any dividend to the Company for the years presented. Certain information and footnote disclosures generally included in financial statements prepared in accordance with U.S. GAAP have been condensed and omitted. The footnote disclosures contain supplemental information relating to the operations of the Company, as such, these statements are not the general-purpose financial statements of the reporting entity and should be read in conjunction with notes to consolidated financial statements of the Company.
As of December 31, 2024 and 2025, except for the investment commitment disclosed in Note 27(a), the Company did not have any significant capital and other commitments, or guarantees.
 
Condensed Balance Sheets
  
As of December 31,
 
    
2024
    
2025
 
ASSETS
     
Current assets
     
Cash and cash equivalents
     1,651,285        1,167,864  
Short-term deposits
     11,938,371        9,898,566  
Long-term deposits, current portion
     —         574,758  
Prepayments and other current assets
     15,502        2,859  
  
 
 
    
 
 
 
Total current assets
     13,605,158        11,644,047  
  
 
 
    
 
 
 
Non-current
assets
     
Investments in subsidiaries and VIEs
     17,114,366        18,141,770  
Long-term investments
     724,548        864,857  
  
 
 
    
 
 
 
Total
non-current
assets
     17,838,914        19,006,627  
  
 
 
    
 
 
 
Total assets
     31,444,072        30,650,674  
  
 
 
    
 
 
 
 
 
Condensed Balance Sheets (continued)
  
As of December 31,
 
    
2024
    
2025
 
LIABILITIES
     
Current liabilities
     
Accruals and other liabilities
     1,344        1,075  
Derivative liability
   —       281,009  
  
 
 
    
 
 
 
Total current liabilities
     1,344        282,084  
  
 
 
    
 
 
 
Non-current liabilities
     
Derivative liability
     167,940        —   
  
 
 
    
 
 
 
Total
non-current
liabilities
     167,940        —   
  
 
 
    
 
 
 
Total liabilities
     169,284        282,084  
  
 
 
    
 
 
 
SHAREHOLDERS’ EQUITY
     
Class A Ordinary shares
     104        105  
Class B Ordinary shares
     21        21  
Additional
paid-in
capital
     70,671,685        71,236,011  
Statutory and other reserves
     95,019        137,720  
Accumulated deficit
     (41,585,549      (42,767,710
Accumulated other comprehensive income
     2,093,508        1,762,443  
  
 
 
    
 
 
 
Total shareholders’ equity
     31,274,788        30,368,590  
  
 
 
    
 
 
 
Total liabilities and shareholders’ equity
     31,444,072        30,650,674  
  
 
 
    
 
 
 
 
 
Condensed Statements of Comprehensive Loss
  
For the Year Ended December 31,
 
    
2023
    
2024
    
2025
 
Operating expenses
        
Selling, general and administrative expenses
     (28,511      (16,706      (15,401
  
 
 
    
 
 
    
 
 
 
Total operating expenses
     (28,511      (16,706      (15,401
  
 
 
    
 
 
    
 
 
 
Fair value gain (loss) on derivative liability relating to the contingent consideration
     29,339        234,245        (117,305
  
 
 
    
 
 
    
 
 
 
Gain (Loss) from operations
     828        217,539        (132,706
Interest income
     601,475        783,148        526,262  
Equity in loss of subsidiaries and VIEs
     (10,165,831      (6,376,372      (2,479,729
Other
non-operating
income, net
     17,718        88,592        21,169  
Exchange (loss) gain from foreign currency transactions
     (473,467      (455,608      849,932  
Investment (loss) gain on long-term investments
     (821      (18,489      44,684  
Fair value loss on derivative assets or derivative liabilities
     (410,417      —         —   
  
 
 
    
 
 
    
 
 
 
Loss before income tax expenses and share of results of equity method investees
     (10,430,515      (5,761,190      (1,170,388
  
 
 
    
 
 
    
 
 
 
Income tax expenses
     —         (5      —   
Share of results of equity method investees
     54,740        (29,069      30,928  
  
 
 
    
 
 
    
 
 
 
Net loss
     (10,375,775      (5,790,264      (1,139,460
  
 
 
    
 
 
    
 
 
 
Net loss attributable to ordinary shareholders of XPeng Inc.
     (10,375,775      (5,790,264      (1,139,460
  
 
 
    
 
 
    
 
 
 
Net loss
     (10,375,775      (5,790,264      (1,139,460
Other comprehensive income (loss)
        
Foreign currency translation adjustment, net of tax
     286,614        262,870        (331,065
  
 
 
    
 
 
    
 
 
 
Total comprehensive loss attributable to XPeng Inc.
     (10,089,161      (5,527,394      (1,470,525
  
 
 
    
 
 
    
 
 
 
Comprehensive loss attributable to ordinary shareholders of XPeng Inc.
     (10,089,161      (5,527,394      (1,470,525
  
 
 
    
 
 
    
 
 
 
 
 
 
Condensed Statements of Cash Flows
  
For the Year Ended December 31,
 
    
2023
    
2024
    
2025
 
Cash flows from operating activities
     520,066        683,003        602,382  
Cash flows from investing activities
        
Maturity (placement) of term deposits
     4,164,149        (1,961,056      1,140,950  
Investment in equity investees
     (5,306,987      (2,257,875      (2,215,607
Cash paid for long-term investments
     (188,681      (144,192      (103,434
Disposal of long-term investments
     —         —         28,571  
  
 
 
    
 
 
    
 
 
 
Net cash used in investing activities
     (1,331,519      (4,363,123      (1,149,520
  
 
 
    
 
 
    
 
 
 
Cash flows from financing activities
        
Proceeds from issuance of ordinary shares to Volkswagen
     5,019,599        —         —   
  
 
 
    
 
 
    
 
 
 
Net cash provided by financing activities
     5,019,599        —         —   
  
 
 
    
 
 
    
 
 
 
Effects of exchange rate changes on cash, cash equivalents and restricted cash
     27,795        143,808        63,717  
Net increase (decrease) in cash, cash equivalents and restricted cash
     4,235,941        (3,536,312      (483,421
Cash, cash equivalents and restricted cash at beginning of the year
     951,656        5,187,597        1,651,285  
  
 
 
    
 
 
    
 
 
 
Cash, cash equivalents and restricted cash at end of the year
     5,187,597        1,651,285        1,167,864  
  
 
 
    
 
 
    
 
 
 
 
  (i)
Basis of presentation
The Company’s accounting policies are the same as the Group’s accounting policies with the exception of the accounting for the investments in subsidiaries and VIEs.
For the Company only condensed financial information, the Company records its investments in subsidiaries and VIEs under the equity method of accounting as prescribed in ASC 323, Investments—Equity Method and Joint Ventures.
Such investments are presented on the Condensed Balance Sheets as “Investments in subsidiaries and VIEs” and shares of the subsidiaries and VIEs’ loss are presented as “Equity in loss of subsidiaries and VIEs” on the Condensed Statements of Comprehensive Loss. The parent company only condensed financial information should be read in conjunction with the Group’s consolidated financial statements.